AcelRx Pharmaceuticals Fundamental Score
AcelRx Pharmaceuticals Fundamental Score Chart
View Fundamental Score for ACRX.
Start Your YCharts Pro Gold Membership.
AcelRx Pharmaceuticals Historical Fundamental Score Data
Pro Data ExportThere is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | Go Pro |
About Fundamental Score
The fundamental score is YCharts proprietary score of how strong a company's fundamentals are. It ranges from 1 to 10, with 10 being the strongest. The ten tests are as follows (score one point for each test the company passes):
1) EPS Growth > 0
2) Revenue Growth > 0
3) Five Year Average ROE > 5%
4) 10 Year Minimum Gross Margin > 0
5) Book Value Per Share Growth > 0
6) Current Ratio > 1
7) Debt to Equity Ratio < 13
8) 10 Year Average Cash Flow > 0
9) Long Term Debt < 5 x Net Income
10) Uninterrupted dividend payments as far back as we have data
(unless otherwise noted, growth rates are calculated for 10 years or the life of the stock, whichever is shorter)
Further details can be found in our support center article about the fundamental score.
Learn More
View Fundamental Score for ACRX.
Start Your YCharts Pro Gold Membership.
Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle.
YCharts Pro is only $49/month, and comes with a 14-day free trial.
Get Started NowAlready a YCharts Pro Gold Member? Sign in here.
ACRX Fundamental Score Benchmarks
| Companies | |
|---|---|
| Cyanotech Corporation | Go Pro |
| Intercept Pharmaceuticals | Go Pro |
| KYTHERA Biopharmaceuticals | Go Pro |
ACRX Fundamental Score Rankings
| Overall |
45th percentile 4164 of 7593 |
| Sector |
26th percentile 480 of 650 in Healthcare |
| Industry |
40th percentile 31 of 52 in Drug Manufacturers - Major |
ACRX Fundamental Score Range, Past 5 Years
| Minimum | Go Pro | Dec 2012 |
| Maximum | Go Pro | Dec 2012 |
| Average | Go Pro |
ACRX News
Seeking Alpha May 8
